SECRETOME THERAPEUTICS ANNOUNCES INITIATION OF THRIVE-2 PHASE 2 CLINICAL STUDY EVALUATING STM-01 IN DUCHENNE MUSCULAR DYSTROPHY

Reuters · 1d ago

Please log in to view news